Table 3.
Proposed Interventions for a Modified Cardiac Enhanced Recovery Program to be Implemented During the COVID-19 Pandemic.
| Intervention | Level of Evidence | Expected Benefit in COVID-19 | Additional Cost | Impact on Workflow | Implementation Complexity | |
|---|---|---|---|---|---|---|
| Preoperative | Smoking and alcohol cessation for 3 weeks before surgery | Moderate | Medium | Low | Low | Low |
| Encourage clear-fluid intake up to 4-hours before surgery | Low | Small | Low | Medium | Low | |
| Provide a liquid carbohydrate beverage 4 hours before surgery | Low | Small | Medium | Medium | Low | |
| Use a surgical-site infection reduction bundle | Moderate | Large | Medium | High | Medium | |
| Intraoperative | Intraoperative multimodal opioid-sparing analgesia | Moderate | Large | Medium | Medium | Medium |
| Administer an intraoperative antifibrinolytic | High | Large | Low | Low | Low | |
| Maintain intraoperative glucose levels below 180 mg/dL (10 mmol/L) | Moderate | Large | Low | Low | Low | |
| Avoid hyperthermia (>37.9°C) or excessively rapid rates during re-warming on cardiopulmonary bypass | Moderate | Large | Low | Medium | Low | |
| Avoid persistent hypothermia (<35°C) postoperatively | Moderate | Large | Low | Medium | Low | |
| Postoperative | Postoperative multimodal opioid-sparing analgesia | Moderate | Large | Medium | Medium | High |
| Optimize strategies to ensure extubation as early as safely possible | Moderate | Large | Low | High | High | |
| Maintain postoperative glucose levels below 180 mg/dL (10 mmol/L) | Moderate | Large | Low | Medium | Medium | |
| Promote early mobilization and removal of tubes, drains, and lines | Moderate | Large | Low | High | High | |
| Ensure chemical thromboprophylaxis is initiated for all patients when appropriate | Moderate | Medium | Low | Low | Medium | |
Adapted from guidelines published by the ERAS Cardiac Society.30
Abbreviations: COVID-19, coronavirus disease 2019.